SEC Info℠ | Home | Search | My Interests | Help | Sign In | Please Sign In | ||||||||||||||||||||
As Of Filer Filing For·On·As Docs:Size Issuer Filing Agent 8/11/22 Achieve Life Sciences, Inc. 10-Q 6/30/22 60:7.3M ActiveDisclosure/FA |
Document/Exhibit Description Pages Size 1: 10-Q Quarterly Report HTML 888K 2: EX-31.1 Certification -- §302 - SOA'02 HTML 22K 3: EX-32.1 Certification -- §906 - SOA'02 HTML 20K 9: R1 Document and Entity Information HTML 75K 10: R2 Consolidated Balance Sheets (Unaudited) HTML 118K 11: R3 Consolidated Balance Sheets (Parenthetical) HTML 39K (Unaudited) 12: R4 Consolidated Statements of Loss and Comprehensive HTML 69K Loss (Unaudited) 13: R5 Consolidated Statements of Cash Flows (Unaudited) HTML 84K 14: R6 Consolidated Statements of Stockholder's Equity HTML 86K (Unaudited) 15: R7 Nature of Business, Basis of Presentation and HTML 28K Going Concern Uncertainty 16: R8 Accounting Policies HTML 23K 17: R9 Government Grant HTML 23K 18: R10 Intangibles HTML 62K 19: R11 License Agreements HTML 27K 20: R12 Fair Value Measurements HTML 132K 21: R13 Convertible Debt HTML 58K 22: R14 Common Stock HTML 207K 23: R15 Commitments and Contingencies HTML 128K 24: R16 Intangibles (Tables) HTML 62K 25: R17 Fair Value Measurements (Tables) HTML 149K 26: R18 Convertible Debt (Tables) HTML 70K 27: R19 Common Stock (Tables) HTML 186K 28: R20 Commitments and Contingencies (Tables) HTML 125K 29: R21 Nature of Business, Basis of Presentation and HTML 43K Going Concern Uncertainty - Additional Information (Detail) 30: R22 Government Grant - Additional Information HTML 31K (Details) 31: R23 Intangibles - Additional Information (Detail) HTML 29K 32: R24 Intangibles - Components of Intangible Assets HTML 28K (Detail) 33: R25 Intangibles - Estimated Future Amortization HTML 30K Expense Related to Intangible Assets (Detail) 34: R26 License Agreements - Additional Information HTML 27K (Detail) 35: R27 Fair Value Measurements - Additional Information HTML 24K (Detail) 36: R28 Fair Value Measurements - Summary of Assets HTML 30K Measured at Fair Value on Recurring Basis (Detail) 37: R29 Fair Value Measurements - Summary of Cash HTML 27K Equivalents (Detail) 38: R30 Fair Value Measurements - Schedule of Aggregate HTML 27K Fair Value of Principal Amount of Convertible Debt (Detail) 39: R31 Convertible Debt - Additional Information HTML 73K (Details) 40: R32 Convertible Debt - Schedule of Convertible Debt HTML 30K Balance (Details) 41: R33 Common Stock - Authorized - Additional Information HTML 27K (Detail) 42: R34 Common Stock - Issued and Outstanding Shares - HTML 57K Additional Information (Detail) 43: R35 Common Stock - Stock Options - Additional HTML 100K Information (Detail) 44: R36 Common Stock - Summary of Stock Options Activity HTML 34K (Detail) 45: R37 Common Stock - Summary of Fair Value of Each Stock HTML 29K Award for Employees and Directors (Detail) 46: R38 Common Stock - Summary of Share-Based Compensation HTML 27K Expense for Stock Options, Restricted Stock and Employee Share Purchase Plan (Detail) 47: R39 Common Stock - Restricted Stock Unit Awards - HTML 30K Additional Information (Detail) 48: R40 Common Stock - Summary of Restricted Stock Unit HTML 37K Award Activity (Detail) 49: R41 Common Stock - Employee Share Purchase Plan - HTML 24K Additional Information (Detail) 50: R42 Common Stock - Summary of Outstanding Warrants HTML 52K (Detail) 51: R43 Common Stock - Common Stock Warrants - Additional HTML 31K Information (Detail) 52: R44 Commitments and Contingencies - Summary of HTML 25K Contractual Obligations (Detail) 53: R45 Commitments and Contingencies - Additional HTML 68K Information (Detail) 54: R46 Commitments and Contingencies - Summary of Future HTML 26K Minimum Annual Lease Payments (Detail) 55: R47 Commitments and Contingencies - Summary of Other HTML 28K Information Related to Leases (Detail) 58: XML IDEA XML File -- Filing Summary XML 109K 56: XML XBRL Instance -- achv-10q_20220630_htm XML 1.57M 57: EXCEL IDEA Workbook of Financial Reports XLSX 73K 5: EX-101.CAL XBRL Calculations -- achv-20220630_cal XML 110K 6: EX-101.DEF XBRL Definitions -- achv-20220630_def XML 496K 7: EX-101.LAB XBRL Labels -- achv-20220630_lab XML 967K 8: EX-101.PRE XBRL Presentations -- achv-20220630_pre XML 710K 4: EX-101.SCH XBRL Schema -- achv-20220630 XSD 150K 59: JSON XBRL Instance as JSON Data -- MetaLinks 288± 436K 60: ZIP XBRL Zipped Folder -- 0001564590-22-029122-xbrl Zip 254K
Download this zipped .zip folder | |
Files: | achv-10q_20220630.htm achv-20220630.xsd achv-20220630_cal.xml achv-20220630_def.xml achv-20220630_lab.xml achv-20220630_pre.xml achv-ex311_7.htm achv-ex321_6.htm g4iegmpx3mfa000001.jpg |
As Of Filer Filing For·On·As Docs:Size Issuer Filing Agent 1/12/23 Achieve Life Sciences, Inc. 424B7 1:173K Donnelley … Solutions/FA 12/29/22 Achieve Life Sciences, Inc. S-3 4:276K Donnelley … Solutions/FA |
As Of Filer Filing For·On·As Docs:Size Issuer Filing Agent 4/27/22 Achieve Life Sciences, Inc. 8-K:1,2,8,9 4/26/22 14:3.8M ActiveDisclosure/FA |